share_log

Invivyd | UPLOAD: Others

Invivyd | UPLOAD: Others

Invivyd | UPLOAD:其他
美股sec公告 ·  02/23 14:09
Moomoo AI 已提取核心訊息
Invivyd, Inc., a biotechnology company, has been informed by the United States Securities and Exchange Commission (SEC) that its Registration Statement on Form S-3, filed on February 9, 2024, will not undergo review by the commission. The SEC's communication, dated February 23, 2024, and addressed to Invivyd's CEO David Hering, explicitly states that the company should not expect a review and reminds them of their responsibility for the accuracy and adequacy of their disclosures. The SEC also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Invivyd and its management have been directed to contact Lauren Hamill for any further inquiries regarding the matter.
Invivyd, Inc., a biotechnology company, has been informed by the United States Securities and Exchange Commission (SEC) that its Registration Statement on Form S-3, filed on February 9, 2024, will not undergo review by the commission. The SEC's communication, dated February 23, 2024, and addressed to Invivyd's CEO David Hering, explicitly states that the company should not expect a review and reminds them of their responsibility for the accuracy and adequacy of their disclosures. The SEC also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Invivyd and its management have been directed to contact Lauren Hamill for any further inquiries regarding the matter.
美國證券交易委員會(SEC)已通知生物技術公司Invivyd, Inc.,其於2024年2月9日提交的S-3表格註冊聲明將不接受該委員會的審查。美國證券交易委員會於2024年2月23日致Invivyd首席執行官戴維·赫林的信函明確指出,該公司不應指望得到審查,並提醒他們對披露的準確性和充分性負責。美國證券交易委員會還引用了與加快註冊程序的請求有關的第460和461條。Invivyd及其管理層已被指示聯繫勞倫·哈米爾,以進一步詢問此事。
美國證券交易委員會(SEC)已通知生物技術公司Invivyd, Inc.,其於2024年2月9日提交的S-3表格註冊聲明將不接受該委員會的審查。美國證券交易委員會於2024年2月23日致Invivyd首席執行官戴維·赫林的信函明確指出,該公司不應指望得到審查,並提醒他們對披露的準確性和充分性負責。美國證券交易委員會還引用了與加快註冊程序的請求有關的第460和461條。Invivyd及其管理層已被指示聯繫勞倫·哈米爾,以進一步詢問此事。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息